| Title: |
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial(Investigational New Drugs, (2024), 42, (145-159), 10.1007/s10637-023-01410-2) |
| Authors: |
Armstrong, AJ; Geva, R; Chung, HC; Lemech, C; Miller, WH; Hansen, AR; Lee, JS; Tsai, F; Solomon, BJ; Kim, TM; Rolfo, C; Giranda, V; Ren, Y; Liu, F; Kandala, B; Freshwater, T; Wang, JS |
| Publisher Information: |
SPRINGER |
| Publication Year: |
2024 |
| Collection: |
The University of Melbourne: Digital Repository |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| ISSN: |
0167-6997 |
| Relation: |
https://hdl.handle.net/11343/352466 |
| Availability: |
https://hdl.handle.net/11343/352466 |
| Rights: |
https://creativecommons.org/licenses/by/4.0 ; CC BY |
| Accession Number: |
edsbas.7FE53978 |
| Database: |
BASE |